Thermal Imaging in Liver Disease.
Thermal Imaging of the Peripheral Vasculature in Liver Disease.
1 other identifier
observational
66
1 country
1
Brief Summary
This is a feasibility study, to assess if thermal imaging and/or near infrared imaging will be useful in identifying changes in the peripheral circulation in patients with different stages of liver disease. The aim of this study is to use new and advanced thermal imaging techniques to identify changes in the peripheral circulation and hand temperature in patients with liver disease. These changes could be used as a non-invasive marker of the severity and progression of liver disease. Thermal imaging will also be used to assess the changes in the peripheral vasculature with the use of terlipressin, a drug used as treatment for specific complications of liver disease. Patients with acute or chronic liver disease from any aetiology will be recruited, along with patients without liver disease as healthy controls. Patients with disease or on drugs known to affect the peripheral vasculature will be excluded. All studies will be performed in a ward setting in the Royal Infirmary of Edinburgh. The subjects will be required for up to three sessions, each lasting 30 minutes. The session will involve static thermal images being taken, and video images of the hands warming up after being cooled for 30 seconds in water at a temperature of 7 degrees Celsius. If the patient is receiving terlipressin therapy, static images will be taken before, during and after terlipressin therapy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Sep 2019
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 8, 2017
CompletedFirst Posted
Study publicly available on registry
September 12, 2017
CompletedStudy Start
First participant enrolled
September 1, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2019
CompletedJune 18, 2024
June 1, 2024
Same day
September 8, 2017
June 17, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Changes in peripheral vasculature as assessed by thermal imaging
2 years
Secondary Outcomes (1)
Changes in peripheral vasculature in response to terlipressin therapy.
2 years
Study Arms (2)
Liver disease
15 patients with acute or chronic liver disease of any aetiology. Serial static images to be taken at up to 3 time points using thermal imaging camera. Video images using thermal camera will be used to capture warming of one hand after cooling. Patient may or may not be receiving terlipressin therapy.
Normal
15 patients without liver disease, and without any other disease or drug known to affect the peripheral circulation. Serial static images to be taken at up to 3 time points using thermal imaging camera. Video images using thermal camera will be used to capture warming of one hand after cooling.
Interventions
Use of thermal imaging camera to capture images of peripheral vasculature (hands).
Eligibility Criteria
Patients aged 18-70 with acute or chronic liver disease
You may qualify if:
- diagnosis of chronic liver disease (any stage)
- diagnosis of acute liver disease (any aetiology)
You may not qualify if:
- on drugs known to affect peripheral circulation
- conditions known to affect peripheral circulation e.g. Raynauds
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Univerity of Edinburgh and NHS Lothian
Edinburgh, United Kingdom
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 8, 2017
First Posted
September 12, 2017
Study Start
September 1, 2019
Primary Completion
September 1, 2019
Study Completion
December 1, 2019
Last Updated
June 18, 2024
Record last verified: 2024-06
Data Sharing
- IPD Sharing
- Will not share